David A Loeffler Selected Research

Cognitive Dysfunction

1/2017	Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory study.
7/2013	Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Loeffler Research Topics

Disease

17	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 10/2006
7	Parkinson Disease (Parkinson's Disease) 01/2019 - 06/2009
4	Tauopathies 01/2017 - 01/2015
3	Infections 01/2004 - 09/2003
2	Inflammation (Inflammations) 01/2021 - 10/2004
2	Dementia (Dementias) 01/2021 - 10/2006
2	Disease Progression 01/2020 - 12/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2017
2	Cognitive Dysfunction 01/2017 - 07/2013
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Neuroblastoma 12/2012
1	Parkinsonian Disorders (Parkinsonism) 12/2012
1	Body Weight (Weight, Body) 02/2012
1	Serum Sickness 02/2012
1	REM Sleep Behavior Disorder 01/2012
1	Neoplasms (Cancer) 03/2011
1	Amyloidosis 03/2011
1	Pheochromocytoma 08/2004
1	Granuloma 06/2002

Drug/Important Bio-Agent (IBA)

13	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 01/2010
8	AntibodiesIBA 01/2017 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2012
4	Dopamine (Intropin)FDA LinkGeneric 06/2009 - 09/2003
3	Leucine (L-Leucine)FDA Link 01/2019 - 03/2016
3	Phosphotransferases (Kinase)IBA 01/2019 - 03/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2015
2	SynucleinsIBA 12/2012 - 01/2012
2	Immunoglobulin G (IgG)IBA 12/2012 - 02/2012
2	Amyloid beta-PeptidesIBA 03/2011 - 01/2010
1	ApolipoproteinsIBA 01/2021
1	AlbuminsIBA 01/2020
1	AmbarIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Therapeutic UsesIBA 10/2015
1	Pharmaceutical PreparationsIBA 07/2015
1	Amino Acids FDA Link 07/2015
1	tau Proteins (tau Protein)IBA 07/2015
1	EpitopesIBA 01/2015
1	OctagamIBA 06/2013
1	Blood Proteins (Serum Proteins)IBA 01/2012
1	AntigensIBA 08/2011
1	Amyloid (Amyloid Fibrils)IBA 03/2011
1	Oxidopamine (6 Hydroxydopamine)IBA 06/2009
1	Complement C3b (C3bi)IBA 10/2006
1	Complement System Proteins (Complement)IBA 10/2004
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2004
1	alpha-SynucleinIBA 12/2003
1	UbiquitinIBA 12/2003
1	RNA (Ribonucleic Acid)IBA 12/2003
1	Levodopa (L Dopa)FDA LinkGeneric 12/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2002

Therapy/Procedure

1	Plasmapheresis 01/2020
1	Activities of Daily Living (ADL) 01/2020
1	Therapeutics 01/2017
1	Radiotherapy 03/2011
1	Intravenous Injections 01/2004